Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 32, Issue 6, Pages 893-903
Publisher
Wiley
Online
2017-03-31
DOI
10.1002/mds.26976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
- (2015) Tiago A. Mestre et al. PARKINSONISM & RELATED DISORDERS
- Dextromethorphan/Quinidine for Chorea
- (2012) William G. Ondo CLINICAL NEUROPHARMACOLOGY
- Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors
- (2012) Melanie A. Paquette et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
- (2011) Imtiaz Ahmed et al. BRAIN
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
- (2011) Mahmoud M. Iravani et al. JOURNAL OF NEURAL TRANSMISSION
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
- (2010) Paolo Calabresi et al. LANCET NEUROLOGY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
- (2009) E. Cobos et al. Current Neuropharmacology
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
- Levodopa-induced dyskinesia and striatal signaling pathways
- (2009) A. Pisani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism
- (2009) Melanie A. Paquette et al. PSYCHOPHARMACOLOGY
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started